Grail was founded in 2015 by Richard (Rick) Klausner, MD and Jeff Huber. The company filed its S-1 registration document with the SEC in September 2020 in advance of a planned Initial Public Offering. Subsequently in the same month, Illumia announced in a press release it had reached a definitive agreement to acquire Grail for $8 billion.
Grail is the developer of a pan-cancer screening test designed to detect cancer early. The company has raised approximately $2 billion in Venture Capital funding from investors including ARCH Venture Partners, Bezos Expeditions, Biomatics Capital, GV, Illumina, Foresite Capital Management, McKesson Ventures, Tencent, Amino Capital, Baillie Gifford, Decheng Capital, Dentsu Ventures, 6 Dimensions Capital, and Blue Pool Capital. Per company press releases, Grail last raised $390 million in May 2020 at a post-money valuation of $3.85 billion.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
05/06/2020 | Series D | $392.01MM | $xx.xx | $4.26B | Canada Pension Plan Investment Board, Illumina, Public Sector Pension Investment Board | |
Price per Share
$xx.xx
Shares Outstanding
76,743,836
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Canada Pension Plan Investment Board, Illumina, Public Sector Pension Investment Board
|
||||||
05/21/2018 | Series C | $300MM | $xx.xx | $3.2B | 6 Dimensions Capital, Ally Bridge Group, Blue Pool Capital, China Merchant Securities International, Crf Investment, Hillhouse Capital Group, Huangpu River Capital, Icbc International, Sequoia Capital China, Wuxi Nextcode | |
Price per Share
$xx.xx
Shares Outstanding
63,144,600
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
6 Dimensions Capital, Ally Bridge Group, Blue Pool Capital, China Merchant Securities International, Crf Investment, Hillhouse Capital Group, Huangpu River Capital, Icbc International, Sequoia Capital China, Wuxi Nextcode
|
||||||
11/22/2017 | Series B | $1.24B | $xx.xx | $2.35B | Amazon, Arch Venture Partners, Goldman Sachs, Johnson & Johnson Innovation, Mckesson Ventures | |
Price per Share
$xx.xx
Shares Outstanding
309,256,591
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Amazon, Arch Venture Partners, Goldman Sachs, Johnson & Johnson Innovation, Mckesson Ventures
|
||||||
01/08/2016 | Series A | $85MM | $xx.xx | $212.5MM | Amino Capital, Arch Venture Partners, Bezos Expeditions | |
Price per Share
$xx.xx
Shares Outstanding
85,000,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Amino Capital, Arch Venture Partners, Bezos Expeditions
|